Lexeo Therapeutics, Inc. (LXEO) Operating income 2022–2025
Lexeo Therapeutics, Inc. (LXEO) annual operating income history from SEC filings — each fiscal year as reported.
-$109.3MFY2025 · since FY2022: -$60.5M → -$109.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$109.3M | -3.3% |
| FY2024 | -$105.8M | -54.4% |
| FY2023 | -$68.5M | -13.2% |
| FY2022 | -$60.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LXEO financial trends
LXEO RevenueLXEO Net incomeLXEO Net marginLXEO Gross profitLXEO Gross marginLXEO Operating marginLXEO Operating cash flowLXEO Free cash flowLXEO Capital expendituresLXEO Return on equityLXEO Stock buybacksLXEO Dividends paidLXEO Total assetsLXEO Total liabilitiesLXEO Shareholders’ equityLXEO overview →